ret/PTC-1 activation in hashimoto thyroiditis

Activation of ret/PTC-1 has been documented in a minority of papillary thyr oid carcinomas (PTC). In a recent study, the authors' group detected the pr esence of ret/PTC-1 in association with a background of florid lymphocytic thyroiditis (LT) in 58% of cases of PTC studied, which prompted them to exa mine the incidence of RET/PTC-1 expression in 27 examples of various forms of nonlymphomatous lymphoid infiltration of the thyroid by using TaqMan RT- PCR. Overall, 21 cases (78%) were found to express the chimeric transcript of ret/PTC-1. Eighteen cases of Hashimoto thyroiditis were positive (95%), and, of these, three had concomitant PTC while the remainder had no histolo gic evidence of associated malignancy. Three cases of lymphocytic thyroidit is demonstrated activated ret/PTC-1 (43%), two having associated PTC. These data suggest either that ret/PTC-1 is an indicator of follicular thyroid c ell activation or that ret/PTC-1 activation is an early event in malignant transformation. If the latter is the case, it may be that, in a defined sub set of the cell population, ret/PTC-1 activation elicits an autoimmune resp onse, which, while possibly curtailing the development of PTC in the majori ty of cases, results in destruction of the thyroid parenchyma.